证券记录 · 已归档季度
STE
STERIS plc · Healthcare · Medical - Specialties
16被追踪持有人
—Δ持有人
4.95M持有股份
$1.08B报告持仓市值
+0新建仓位
−0清仓
所有持股数据：仅限已追踪的 13F 管理人，普通股持仓，报告期 Q2 2024
持股变化趋势
| 季度 | 持有人 | Δ | 股份 | 报告持仓市值 | 新增 | 清仓 |
|---|---|---|---|---|---|---|
| Q2 2026 | 154 | 0 | 66.54M | $14.06B | +9 | −9 |
| Q1 2026 | 157 | -2 | 67.44M | $14.98B | +5 | −8 |
| Q4 2025 | 158 | +2 | 70.95M | $17.98B | +3 | — |
| Q3 2025 | 21 | -1 | 36.52M | $9.03B | — | −2 |
| Q2 2025 | 20 | -1 | 31.11M | $7.47B | +1 | −2 |
| Q1 2025 | 18 | +2 | 9.46M | $2.14B | +2 | — |
| Q4 2024 | 16 | +1 | 8.94M | $1.84B | +1 | — |
| Q3 2024 | 14 | -2 | 4.76M | $1.15B | — | −2 |
| Q2 2024 | 16 | — | 4.95M | $1.08B | — | — |
持有人 · Q2 2024
| # | 管理人 | 股份 | Δ股份 | 价值 | 其权重 | 持有 | ||
|---|---|---|---|---|---|---|---|---|
| 1 | Geode Capital Management ✦ (被动) | 2.29M | — | $500.64M | 0.0% | n/c | 1 | SEC ↗ |
| 2 | Geode Capital Management ✦ (被动) | 2.29M | — | $500.64M | 0.0% | n/c | 1 | SEC ↗ |
| 3 | Norges Bank ✦ (被动) | 1.16M | — | $253.78M | 0.0% | n/c | 1 | SEC ↗ |
| 4 | Marshall Wace ✦ | 501.90K | — | $110.19M | 0.2% | n/c | 1 | SEC ↗ |
| 5 | Marshall Wace ✦ | 501.90K | — | $110.19M | 0.2% | n/c | 1 | SEC ↗ |
| 6 | T. Rowe Price ✦ | 421.16K | — | $92.46M | 0.0% | n/c | 1 | SEC ↗ |
| 7 | T. Rowe Price ✦ | 421.16K | — | $92.46M | 0.0% | n/c | 1 | SEC ↗ |
| 8 | Citadel Advisors ✦ | 219.50K | — | $48.19M | 0.0% | n/c | 1 | SEC ↗ |
| 9 | Citadel Advisors ✦ | 219.50K | — | $48.19M | 0.0% | n/c | 1 | SEC ↗ |
| 10 | GAMCO Investors ✦ | 85.55K | — | $18.78M | 0.2% | n/c | 1 | SEC ↗ |
| 11 | Gotham Asset Management ✦ | 85.44K | — | $18.76M | 0.2% | n/c | 1 | SEC ↗ |
| 12 | Two Sigma Investments ✦ | 54.58K | — | $11.98M | 0.0% | n/c | 1 | SEC ↗ |
| 13 | Adage Capital Partners ✦ | 49.79K | — | $10.93M | 0.0% | n/c | 1 | SEC ↗ |
| 14 | Millennium Management ✦ | 30.51K | — | $6.70M | 0.0% | n/c | 1 | SEC ↗ |
| 15 | Bridgewater Associates ✦ | 21.95K | — | $4.82M | 0.0% | n/c | 1 | SEC ↗ |
| 16 | AQR Capital Management ✦ | 15.09K | — | $3.28M | 0.0% | n/c | 1 | SEC ↗ |
| 17 | AQR Capital Management ✦ | 15.09K | — | $3.28M | 0.0% | n/c | 1 | SEC ↗ |
| 18 | Arrowstreet Capital ✦ | 8.17K | — | $1.79M | 0.0% | n/c | 1 | SEC ↗ |
| 19 | D. E. Shaw & Co. ✦ | 5.30K | — | $1.16M | 0.0% | n/c | 1 | SEC ↗ |
| 20 | Wellington Management ✦ | 5.27K | — | $1.16M | 0.0% | n/c | 1 | SEC ↗ |
| 21 | Wellington Management ✦ | 5.27K | — | $1.16M | 0.0% | n/c | 1 | SEC ↗ |
| 22 | Fisher Asset Management ✦ | 1.15K | — | $253,129 | 0.0% | n/c | 1 | SEC ↗ |
"持仓权重"= 该持仓占该管理人已申报13F股权价值的比例——即信念度衡量指标。✦ = 精选管理人。
新增买入方
| 本季度无新增被追踪买入方。 |
已清仓
| 本季度无被追踪的退出仓位。 |
全市场背景: 涵盖所有13F申报机构（SEC结构化数据， Q1 2026): 832 持有人, 93.28M 股份, $19.55B 已申报. 这是与上方被追踪全域数据不同的较早期间，两者从不混用。
常见共同持仓
该证券的被追踪持有人最常同时持有的其他证券——基于共同持有计数，而非基本面关联。
数据来源: 持股数据来源于已解析的13F普通股持仓（被追踪范围，变动对比集）；内部人行为来自Form 3/4/5；重大持股来自Schedule 13D/13G；所有文件均链接至SEC EDGAR原始申报。
报告期: Q2 2024 ·
方法论 ·
通过API获取此数据